Arthrocentesis as initial treatment of arthropathy of the temporomandibular joint

INTERVENTION: Trade Name: Brufen Bruis Pharmaceutical Form: Powder for oral suspension CONDITION: Arthropathy of the temporomandibular joint ; MedDRA version: 9.1 Level: LLT Classification code 10003285 Term: Arthropathy PRIMARY OUTCOME: Main Objective: To study the efficacy of arthrocentesis as initial treatment of arthropathy for reduction of pain and the restoration of mandibular function as compared to usual care. Primary end point(s): Main outcome measure is pain in the TMJ (0 – 100 mm VAS) Secondary Objective: An economic evaluation will be conducted alongside the clinical study to assess the cost‐effectiveness of arthrocentesis in patients with arthropathy of the TMJ. INCLUSION CRITERIA: Patients with pain in the TMJ, suspected for a TMJ intra‐articular disorder. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range